| Possis Medical, Inc. is a developer, manufacturer and marketer of medical devices. Its primary product is the AngioJet Rheolytic Thrombectomy System, a non-surgical, minimally invasive catheter system designed to rapidly remove blood clots with minimal vascular trauma. In April 2000, March 1999 and December 1996, the Company received United States Food and Drug Administration (FDA) clearances to commence United States marketing of the AngioJet System, for removal of blood clots in leg arteries, native coronary arteries and coronary bypass grafts and access grafts used by patients on kidney dialysis, respectively. The AngioJet System is typically used in conjunction with other medical devices, such as angioplasty balloons and stents (both bare metal and drug eluting), and drugs, such as thrombolytics and platelet inhibitors. Possis also markets the XMI, XVG, Xpeedior and AVX catheters. Each of these catheters feature the Company's proprietary Cross-Stream Technology. |
